Shane M. Ward's most recent trade in Cidara Therapeutics Inc was a trade of 135,540 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 135,540 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 50,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 25,083 | 0 (0%) | 0% | 221.5 | 5,555,885 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 12,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 12,499 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 6,207 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.60 per share. | 10 Dec 2025 | 15,041 | 24,633 (0%) | 0% | 219.6 | 3,303,004 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale of securities on an exchange or to another person at price $ 220.08 per share. | 10 Dec 2025 | 9,959 | 25,033 (0%) | 0% | 220.1 | 2,191,747 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.20 per share. | 10 Dec 2025 | 6,459 | 34,592 (0%) | 0% | 20.2 | 130,472 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 6,459 | 6,207 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. | 10 Dec 2025 | 3,500 | 28,133 (0%) | 0% | 16.7 | 58,289 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 3,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 25,000 | 39,674 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 11 Mar 2025 | 1,664 | 14,674 (0%) | 0% | 22.0 | 36,542 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 135,540 | 135,540 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 120,000 | 318,770 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 11 Mar 2024 | 20,473 | 198,770 (0%) | 0% | 0.7 | 13,713 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 253,333 | 253,333 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 126,667 | 211,243 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 13 Mar 2023 | 4,329 | 84,576 (0%) | 0% | 1.5 | 6,623 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 70,000 | 70,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 69,027 | 104,027 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 35,000 | 35,000 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 31 Mar 2022 | 23,122 | 80,905 (0%) | 0% | 0.8 | 19,191 | Common Stock |